Hepatopulmonary syndrome and portopulmonary hypertension

Hepatology Research

Volumn 39, Issue 10, 2009, Pages 1020-1022

  Umeda, Naoki ^a   Kamath, Patrick S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hepatopulmonary syndrome; Portopulmonary hypertension

Indexed keywords

ALBUMIN TC 99M; BOSENTAN; ILOPROST; OXYGEN; PROSTACYCLIN; SILDENAFIL; SODIUM CHLORIDE;

ARTICLE; BLOOD VESSEL SHUNT; CLINICAL FEATURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FATIGUE; HEART CATHETERIZATION; HEART FAILURE; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG SCINTISCANNING; MEDICAL DECISION MAKING; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; THORAX RADIOGRAPHY; TREATMENT CONTRAINDICATION;

EID: 73849105787     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00552.x     Document Type: Article

References (16)

1. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology 1990; 11: 138-42.
2. Naeije R, Melot C, Hallemans R et al. Pulmonary hemodynamics in liver cirrhosis. Semin Respir Med 1985; 7: 164.
3. Krowka MJ, Cortese D.A. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 1994; 105: 1528-37.
4. Swanson KL, Wiesner RH, Krowka M.J. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005; 41: 1122-9.
5. Swanson K.L. Should we screen for hepatopulmonary syndrome in liver transplant candidates? Liver Transpl 2007; 13: 183.
6. Rodriguez-Roisin R, Krowka MJ, Fallon MB et al. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 2004; 24: 861-80.
7. Lebrec D, Capron JP, Benhamou JP et al. Pulmonary hypertension complicating portal hypertension. Am Rev Respir Dis 1979; 120: 849-56.
8. Gaine SP, Rubin L.J. Primary pulmonary hypertension. Lancet 1998; 352: 719-25.
9. Fuster V, Steele PM, Frye RL et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984; 70: 580-7.
10. McLaughlin VV, Genthner DE, Rich S et al. Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. Ann Intern Med 1999; 130: 740-3.
11. Krowka MJ, Frantz RP, Wiesner RH et al. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 1999; 30: 641-8.
12. Halank M, Miehlke S, Hoeffken G et al. Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension. Transplantation 2004; 77: 1775.
13. Chua R, Keogh A, Miyashita M. Novel use of sildenafil in the treatment of portopulmonary hypertension. J Heart Lung Transplant 2005; 24: 498-500.
14. Latiff K, Meanger J, Ghildyal R. Sequence and structure relatedness of matrix protein of human respiratory syncytial virus with matrix proteins of other negative-sense RNA viruses. Clin Microbiol Infect 2004; 10: 945-8.
15. Halank M, Marx C, Hoeffken G. Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension. J Gastroenterol 2004; 39: 1222.
16. Robalino BD, Moodie D.S. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations J Am Coll Cardiol 1991; 17: 492-8.